Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01687270 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

A Phase 2 study of Post Liver Transplant and Recurrent Chronic Hepatitis C Virus, sponsored by Gilead Sciences.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
12
Study locations

NCT01687270 is a Phase 2 study of Post Liver Transplant and Recurrent Chronic Hepatitis C Virus that has completed, run by Gilead Sciences. The registered enrollment target is 40 participants. The trial reports 12 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01687270, a Phase 2 study of Post Liver Transplant and Recurrent Chronic Hepatitis C Virus, has completed, sponsored by Gilead Sciences.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
12
Study locations

Study Summary

This is an open-label, single-arm study of sofosbuvir (GS-7977) and ribavirin (RBV) in adults who have had a liver transplant which has become re-infected with hepatitis C. The treatment period is 24 weeks with up to 48 weeks of follow up. The total time in this study will last up to 72 weeks not including the screening visit.

Conditions Studied

Post Liver Transplant Recurrent Chronic Hepatitis C Virus

Interventions

  • DRUG RBV
  • DRUG Sofosbuvir

Study Locations (12)

New York

  • - New York
  • - New York

California

  • - San Francisco

Indiana

  • - Indianapolis

Kansas

  • - Kansas City

Massachusetts

  • - Boston

Michigan

  • - Ann Arbor

Minnesota

  • - Rochester

Other

  • - Villejuif

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-11
Est. Completion 2014-08
Phase Phase 2

Sponsor

Gilead Sciences

504 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01687270

The ClinicalTrials.gov registry entry for NCT01687270 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Post Liver Transplant appearing as the primary indexed condition, and to 2 interventions - of which RBV is the first listed.

NCT01687270 reports 12 study locations spanning 11 distinct geographic areas - top geographies include New York, California, Indiana.

Frequently Asked Questions

What is clinical trial NCT01687270 about?

NCT01687270 is a clinical study titled "Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant". This is an open-label, single-arm study of sofosbuvir (GS-7977) and ribavirin (RBV) in adults who have had a liver transplant which has become re-infected with hepatitis C. The treatment period is 24 weeks with up to 48 weeks of follow up. The total time in this study will last up to 72 weeks not in...

What is the current status of trial NCT01687270?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2012-11. Estimated completion is 2014-08.

What conditions does trial NCT01687270 study?

This clinical trial studies the following conditions: Post Liver Transplant, Recurrent Chronic Hepatitis C Virus.

What interventions are being tested in trial NCT01687270?

The interventions under investigation include: RBV (DRUG), Sofosbuvir (DRUG).

Who is sponsoring clinical trial NCT01687270?

This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01687270 being conducted?

This trial has 12 study locations across California, Indiana, Kansas, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Liver Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Post Liver Transplant

All registered trials for this condition

Recurrent Chronic Hepatitis C Virus

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.